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ABSTRACT
U
nderstanding mammalian genetic systems is
predicated on the determination of the relationship
between genetic variation and phenotype. Several
international programmes are under way to deliver
mutations in every gene in the mouse genome. The challenge
for mouse geneticists is to develop approaches that will
provide comprehensive phenotype datasets for these mouse
mutant libraries. Several factors are critical to success in this
endeavour. It will be important to catalogue assay and
environment and where possible to adopt standardised
procedures for phenotyping tests along with common
environmental conditions to ensure comparable datasets of
phenotypes. Moreover, the scale of the task underlines the
need to invest in technological development improving both
the speed and cost of phenotyping platforms. In addition, it
will be necessary to develop new informatics standards that
capture the phenotype assay as well as other factors, genetic
and environmental, that impinge upon phenotype outcome.
Introduction
The phenotype of an organism is a complex product of its
genetic constitution and various environmental inﬂuences.
Determining and measuring phenotype has been a goal of all
biologists, as the phenotype is an indicator of how an
organism functions in different environments and under
various challenges and insults. Comparative phenotyping
underlies studies of evolutionary processes and how
organisms adapt to their environment. Moreover, the
phenotype is fundamental to understanding how genes
function and how they determine both the developmental
processes and the biochemical and physiological makeup of
an organism. We cannot hope to understand an organism and
the relationship between gene and phenotype without
developing tools and techniques to study, measure, and
annotate the phenotype.
Classically, geneticists have studied the relationship
between genes and phenotype by the introduction of
mutations in experimental organisms, the identiﬁcation of
novel phenotypes that arise from those mutations, and the
investigation of the link between mutation and phenotype. In
addition, population and evolutionary biologists study the
relationships between changes in phenotypes between
populations and species and underlying changes in allele
frequencies. However, the issue of phenotyping has been
thrown into focus by the establishment of programmes in
several experimental organisms to systematically mutate
every gene in the genome and determine the phenotype of
each mutant. The aim of such programmes is to provide a
systematic and comprehensive underpinning to a systems
biology of these organisms where the relationship between
mutant and phenotype is a key component to establishing a
fundamental understanding of molecular and cellular
processes. If we are to generate meaningful datasets that
contribute to such an endeavour, it is clear that any
determination of phenotype needs to be comprehensive. This
sets apart these programmes from their predecessors where
investigators focused on one or a few phenotypes of interest
within their sphere of study. Geneticists are faced with
developing approaches to phenotyping that encompass all
developmental and physiological systems and that can be
applied to a very large number of mutants. This will be a
phenomenal undertaking in any organism, especially for the
mouse.
Mouse Models of Human Disease—Mutagenesis
Programmes and Phenotyping
The mouse is the key model organism for the analysis of
mammalian developmental, physiological, and disease
processes [1]. It is the preeminent organism for the
development and study of models of human diseases, and for
many years it has not only provided insights into fundamental
biological processes but also has played a major role in
identifying genetic loci involved with disease susceptibility. A
draft mouse genome sequence was published in 2002 [2], and
a ﬁnished sequence will soon be available. The challenge for
mammalian genetics in the 21st century is to build on the
mouse sequence map and develop a comprehensive
functional annotation of the mouse genome that will provide
a rich resource for understanding human gene function.
There is already available an extensive genetic toolkit to
modify the mouse genome and to study the relationship
between gene and phenotype. There are two distinct
approaches to mouse mutagenesis—gene-driven and
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lesion is introduced into the mouse genome followed by
investigation of its phenotype. Gene-driven approaches
include gene-traps, targeted traps, and both targeted knock-
out and knock-in mutations [5–8]. In contrast, the phenotype-
driven approach aims to search large random collections of
mutations, usually generated by ENU (ethyl-nitrosourea)
mutagenesis, for phenotypes of interest irrespective of the
underlying lesion generated [9–11]. Thus the phenotype is the
starting point, and after discovery of an interesting
phenotype the underlying genetic lesion is identiﬁed and
investigated further. Both approaches depend upon
phenotyping tools.
With the completion of the mouse genome sequence and
the availability of powerful and affordable toolkits for mouse
mutagenesis, there has been much public discussion of
programmes to generate mutation resources for all mouse
genes, principally using a range of gene-driven approaches
[12,13]. Two such programmes, European Conditional Mouse
Mutagenesis Programme and North American Conditional
Mouse Mutagenesis Programme, focusing on generating
libraries of embryonic stem cells carrying conditional
mutations, are now funded and under way. It can be expected
that additional programmes funded through the Knockout
Mouse Project initiative in the United States will follow. ENU
mutagenesis approaches, both phenotype-driven and gene-
driven [14], will also make a signiﬁcant contribution.
Ultimately, comprehensive libraries of mouse mutants for
every gene in the genome will be generated. Indeed, the goal
of mouse geneticists is to have available a range of mutant
alleles for every gene, including hypomorphs, gain-of-
function, and dominant negatives, as well as null alleles. All of
these mutations will require phenotyping. How do we achieve
this and what are the challenges that face us in providing a
comprehensive functional annotation of the mouse genome?
The Challenges of Phenotyping
It is important to emphasise that phenotype is a complex
output of gene allele, genetic background, environment, and
the speciﬁc test applied. We can view phenotype as a complex
matrix of these interacting factors (see Figure 1). For any
gene, there will be multiple alleles to be investigated,
potentially on multiple genetic backgrounds. The phenotype
may be subject to many environmental inﬂuences, ranging
from husbandry practices and cage environment to the
pathogen spectrum. Finally, the phenotype test itself is a
major contributing factor. How the test is performed may
inﬂuence the measured output. In essence the ultimate goal
of mouse genetics is to populate multiple matrices with
phenotype data reﬂecting allele and genetic background,
environmental conditions, and test details. The implication
of this is that we need to standardise our approaches to how
we undertake phenotyping. If mouse genetic centres around
the world use various environmental conditions or adopt
quite different test procedures, then much of the ensuing
datasets will not be comparable. Importantly, we need to be
able to share and compare datasets, allowing us to ask simple
questions such as: Is the phenotype of allele 1 (measured in
centre 1) the same as the phenotype of allele 2 (measured in
centre 2); is the phenotype in allele 3 (measured in centre 3)
different from the phenotype of allele 4 (measured in centre
4), or, trivially, was it simply the way the test procedure was
implemented? We also need to be able to share relevant data
with researchers concerned with the analysis of human
disease, requiring us to work closely with clinical colleagues
to design phenotyping experiments with this in mind. These
simple questions indicate the depth of the problem and they
mirror a wider concern in developing a systems biology of
any organism, that is, the need for standardised datasets,
appropriately annotated and underlined by uniform,
systematic vocabularies [15].
The fundamental role of the assay in standardisation of
phenotyping. To varying degrees, the phenotype assay is
clearly crucial to determining the measured output. This
would argue for adopting standardised approaches, or
standard operating procedures (SOPs), for phenotyping. But
to what extent do we need to ensure that assay and
environmental conditions are monitored and as far as
possible standardised to ensure comparability of datasets
across time and place?
For some phenotypes, such as clinical biochemistry
parameters, the output and its accuracy will depend on the
equipment used (in this case an autoanalyser) and its inherent
accuracy. Different machines may give different accuracies,
underlining the need to record the equipment used.
However, even in what are regarded as very standard
measurements employing common equipment, other
signiﬁcant variables may contribute to the output, such as
bleeding method, time of bleeding, diet, and so on. One study
of the impact of caging and diet on various blood
biochemistry parameters found little inﬂuence on
phenotypes measured across a number of inbred strains [16].
However, it is just such evidence-based studies that are
required to understand the inherent variables that must be
controlled and to develop robust phenotyping platforms
employing SOPs.
For other phenotype assays, there is substantive evidence
that the SOP and environmental conditions are critical. Most
notably, for complex behavioural tests, equipment design,
equipment operation, and environmental conditions have a
very signiﬁcant impact on a test. For example, the design and
operation of an open ﬁeld can have a marked effect on test
output. The position at which a mouse is introduced into an
open ﬁeld can have signiﬁcant impact on test scores and thus
on interlaboratory comparability. In a landmark study
comparing behavioural test outcomes across a number of
laboratories, Crabbe et al. found considerable variation
between laboratories despite efforts to standardise
procedures [17]. While the reasons remain unclear, it is
possible that unrecognised factors, in test or environmental
procedures, contributed to the variation. It would be wrong
to conclude that behavioural testing is fraught with
difﬁculties, rather that even greater efforts are needed to
examine the causes of variation in test procedures. Indeed,
the Eumorphia Project (European Union Mouse Research for
Public Health and Industrial Applications) (http://
www.eumorphia.org), a collaborative research programme
funded by the European Commission, has made a major
effort to standardise and validate procedures for behavioural
tests both within and between laboratories [18]. While many
tests were validated, others showed considerable variation in
test output between laboratories and require further
examination and elimination of test variables.
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multiple environmental inﬂuences, including cage housing
and environmental enrichment. One recent study by Wolfer
and colleagues [19] investigated the effect of enrichment on
the variance contributed by strain x laboratory interactions.
They demonstrated that enrichment effects were highly
consistent across laboratories and dismissed concerns that
enrichment might disrupt standardisation. However,
intriguingly, they also found that environmental enrichment
had little inﬂuence on strain ranking in their response to
several behavioural tests. This study, though, underlines the
difﬁculties we face. Only two strains were used in the Wolfer
study and inevitably not all available behavioural tests were
examined. By contrast, the Eumorphia Project, employing a
wider set of inbred strains and additional tests, found that
environmental enrichment clearly affected strain ranking for
some inbred strains under several behavioural tests [20]. For
other tests, there were no changes in strain ranking.
In conclusion, it is important to catalogue both the assay
and the environmental conditions in which the test was
performed. Moreover, we can conclude that adopting SOPs
and as far as possible adopting common environmental
conditions will assist in the population of comparable
datasets of phenotypes. We discuss below what progress is
being made towards delivering common, standardized
phenotyping platforms.
The importance of throughput—Hierarchies of tests. Given
the numbers of mutant mice that will need to be tested to
develop a complete functional annotation of the mouse
genome, there has been considerable emphasis on developing
tests with high throughput that can be used to rapidly screen
large numbers of mice. To date the prevailing wisdom has
been to employ a hierarchical approach to phenotyping
whereby in the ﬁrst instance rapid, comprehensive test
batteries, often utilising relatively unsophisticated tests, are
applied to large numbers of mice—so-called primary screens.
Primary screens provide a superﬁcial but broad assessment of
mouse phenotype. Subsequently, mice identiﬁed with
potential phenotypes of interest are the focus of more time-
consuming, in-depth sophisticated tests—the secondary and
tertiary screens (see Figure 2). A number of test batteries have
been proposed that employ this hierarchical approach
focusing either on speciﬁc functional domains, e.g., behaviour
[21,22], or employing a wider selection of screens, e.g.,
SHIRPA (SmithKline Beecham, Harwell, Imperial College,
Royal London Hospital Phenotype Assessment) [23], a
comprehensive phenotype assessment tool involving a battery
of up to 40 simple tests (http://www.mgu.har.mrc.ac.uk/
facilities/mutagenesis/mutabase/shirpa_summary.html).
Clearly, there are not ﬁxed boundaries between primary and
secondary/tertiary screens and, depending upon investment
and resources, even quite sophisticated tests can be employed
as primary screens.
Bringing technology to phenotyping—Speed and
sophistication. The challenge for the future is to reverse the
traditional inverse relationship between throughput and
sophistication. This is particularly important if we recognise
that the phenotype description of a mutant mouse needs to
be both comprehensive and deep if we are to fully
understand gene function and integrate it with various
hierarchical systems descriptions at cellular and
physiological levels. Clearly we can address this challenge by
investment in new technology bearing on equipment and test
design that brings speed and sophistication to the phenotype
platform, as well as improvements in cost (see Figure 2). Even
quite complex behavioural assays, such as circadian rhythm
and sociability, have beneﬁted from elaborate automation
and data capture and can be utilised as primary screens
[24,25]. In the future, we can expect microtechnologies and
remote monitoring to have a signiﬁcant impact on the speed
and ﬂexibility of phenotype screens. Already, new
technologies such as Luminex are set to revolutionise the
DOI: 10.1371/journal.pgen.0020118.g001
Figure 1. Phenotype Data Is a Complex Three-Dimensional Matrix of Information Comprising Phenotype Outputs from a Large Number of Tests on
Individual Mutants in Defined Genetic Backgrounds under Specific Environmental Conditions
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proteins [26].
In contrast, some areas of phenotype analysis, such as
pathology or gene expression microarray analysis, for the
moment remain inexorably ﬁxed as a secondary or tertiary
screen, given the difﬁculties of automating tissue and section
analysis from a large number of organs and the requirement
for expert assessment of each and every stained section
[27,28]. The importance of pathology in mouse phenotyping
cannot be underestimated. However, the laborious nature of
pathology analysis and the dependence on a small cadre of
experts continues to represent a signiﬁcant stumbling block
to unravelling the mouse phenome.
Controlling for phenotype variation—Controls and genetic
background. In assessing phenotypes, the issue of controls
and genetic background deserves some attention. It is
common practice to cross mutants generated in 129
embryonic stem cells onto a C57BL/6 background. Indeed, the
C57BL/6 background is the preferred background for
phenotype analysis in a number of systems, including
neurology, behaviour, and immunology. However, relatively
few mutants are backcrossed sufﬁciently (ten or more
generations) to develop congenic lines for which C57BL/6
mice would act as appropriate controls. Generally, control
mice are wild-type sibs generated from the same intercrosses
used to generate homozygous mutant mice, and both mutant
and wild-type mice will contain segregating portions of 129
and C57BL/6 genomes. It is possible that this has led to some
of the variation seen in mutant phenotypes both within and
between laboratories. However, if, as seems likely, mutants
will be produced in a new generation of C57BL/6 embryonic
stem cell lines, it will be possible to readily create all
mutations on a pure inbred C57BL/6 background, avoiding
the current pitfalls. If this can be done, what of the necessary
controls? Undertaking the necessary heterozygous
intercrosses on the shelf to generate sufﬁcient age-matched
homozygotes and wild-type sibs for phenotype analysis is both
time-consuming and costly. With the advent of in vitro
DOI: 10.1371/journal.pgen.0020118.g002
Figure 2. Examples of New Phenotyping Platforms and Imaging Approaches Which Are Beginning to Be Applied, or Being Considered, for High
Throughput Mouse Phenotype Screens on a Large Number of Mutant Animals
The table is not comprehensive but provides exemplars of tests where technological developments are providing improvements in speed and cost that
will enable their utilisation in broad primary screens of mouse mutants. Note that there is increasingly the potential for generic molecular phenotyping
approaches such as gene expression and protein arrays that impact upon multiple phenotyping domains to be applied as primary screens.
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straightforward and efﬁcient in the case of viable mutants to
generate large numbers of age-matched homozygotes for
analysis by in vitro fertilisation. At the same time, a rolling
baseline of wild-type phenotype data could be produced by
intermittent analysis of the C57BL/6 background strain.
Economies such as these will be necessary, given the
phenomenal workload that will be required to analyse the
tens of thousands of mutants over the coming years.
Landmarks in Phenotyping
In addressing the challenges of mouse phenotyping, it is
worth cataloguing some landmarks along the road, several of
which point us towards future directions.
Irwin, the SHIRPA screen, and other primary screens. In
1968, Irwin [30] developed one of the ﬁrst primary screens for
assessing pharmacological and toxicological responses. This
was adapted to develop a general primary screen for mouse
mutant phenotypes called SHIRPA [9,23]. It consists of a
battery of about 40 simple tests, subsets of which address
deﬁcits in spinocerebellar, autonomic, neuropsychiatric,
neuromuscular, and sensory function. SHIRPA was
successfully used as a primary screen in one of the ﬁrst major
phenotype-driven ENU mutagenesis programmes to identify
potential mutant phenotypes of interest [9]. It has been used
subsequently, usually in a modiﬁed form, in other ENU
mutagenesis programmes, as well as being employed as a
general screen for the primary phenotypic characterisation
of mutant mice [31]. At the same time as SHIRPA was
developed, attention was being given to the development of
hierarchical screens that delivered phenotyping platforms for
speciﬁc systems, including behaviour [21]. These ﬁrst
attempts to develop systematic, robust phenotyping screens
are the forerunner of later efforts to develop more
comprehensive, validated sets of primary screens, such as
EMPReSS (European Mouse Phenotyping Resource for
Standardised Screens) (http://www.empress.har.mrc.ac.uk/), a
database of phenotype screens that can be used to phenotype
a mouse.
The Mouse Phenome Project. In 2000, the Jackson Lab
began a programme—the Mouse Phenome Project—initiated
by Ken Paigen to develop a comprehensive database of
phenotypes from the mouse inbred strains [32,33] (http://
www.jax.org/phenome). The project did not envisage an
organised programme of mouse phenotyping either locally or
distributed. The main intention was to provide a database for
the collation and dissemination of phenotypes developed on
sets of mouse inbred strains collected by diverse research
groups. The Mouse Phenome Project encouraged research
groups to contribute and make available their data through
the Jackson Lab portal. The database provides several tools
for downloading and viewing the phenome data. Crucially,
the Mouse Phenome Project recognised the importance of
baseline phenotypes of inbred strains as a key underpinning
for mouse genetics studies and the key value of systematic
phenotype information.
The Eumorphia Project. In 2003, a consortium of European
laboratories began a programme to develop standardised
phenotyping platforms that allow reproducibility of test
outcome over time and place [34], and in so doing address one
of the key challenges for the future of phenotyping. The
consortium comprises 18 research institutes working on
establishing and validating new phenotyping methods.
Eumorphia has developed a new robust primary screening
protocol, EMPReSS. EMPReSS incorporates more than 150
SOPs and associated annexes and appendices, many validated
on a cohort of inbred strains across a number of laboratories.
EMPReSS SOPs are available for all the major body systems,
and also include SOPs for generic approaches such as imaging,
pathology, and gene expression. Ultimately, the community
needs to build on the Eumorphia programme, enlarging the
resource of available SOPs to secondary and tertiary tests and
to provide a comprehensive resource of standardised and
validated screens, bringing further comparability and
reproducibility to phenotyping platforms. It will be important
as mouse genetics centres around the world begin the task of
phenotyping the many mutant lines emerging from the
European Conditional Mouse Mutagenesis Programme, North
American Conditional Mouse Mutagenesis Programme, and
Knockout Mouse (a collaborative research project to be
funded by the NIH) projects, as well as recombinant inbred
strains such as those developed by the Complex Trait
Consortium [35], that standardised phenotyping platforms
such as EMPReSS or others are employed.
The Mouse Clinic—The future of mouse phenotyping. Even
with rapid, standardised protocols applicable to diverse
cellular and physiological systems, there is still a phenomenal
mountain to climb to complete the phenotyping of mutant
alleles for every gene in the genome. Moreover, it is
unrealistic to expect many laboratories to have available the
expertise or the equipment and infrastructure to carry out
comprehensive phenotyping of mutant alleles of local
interest. Consequently, the concept of mouse clinics has
emerged. There are a number of mouse genetics institutes
around the world that have broad expertise in phenotyping
and can be classiﬁed as phenotyping centres. A few of these
have adopted the clinic concept and offer their phenotyping
expertise to external users—these include the German Mouse
Clinic (http://www.empress.har.mrc.ac.uk/) at the GSF
National Research Centre for Environment and Health in
Munich (http://www.gsf.de/ieg/gmc/) [36], and the Mouse
Clinical Institute—Institute Clinique de la Souris in
Strasbourg (http://www-mci.u-strasbg.fr/index.html). It is clear
that if we are to accomplish a comprehensive functional
annotation of the mouse genome, we will need to develop
additional phenotyping centres if we are to generate the scale
of infrastructure that will meet the inherent phenotyping
demands. Many of these phenotyping centres would
undoubtedly operate as clinics, offering services to the wider
community as well as being centres for phenotyping
development. It is important to emphasise that it is likely that
these clinics will be at the centre of distributed networks of
phenotyping able to call on smaller centres with the specialist
expertise to carry out more sophisticated experiments in a
particular area. By working together, the clinics and these
more specialised centres will collectively push the boundaries
of phenotyping technology and application.
Information Systems for Phenotyping—Ontologies
and Databases
As discussed above, we cannot expect to observe a simple
one-to-one relationship between individual mutations and
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from genotype to phenotype to take place via complex
patterns of genetic interactions and environmental
conditions (systems biology). Except in the simplest of cases,
systems analysis will require the use of computational tools to
infer patterns of interaction and model genotype–phenotype
relationships. To make best use of computational systems
biology approaches, it will be necessary to develop
sophisticated ways of representing phenotype data and easily
accessible databases of phenotype information related to
genetic background and other relevant information.
Representing phenotypic information in a standardised
manner presents new challenges for bioinformatics, which
has traditionally concerned itself with simpler data types
(DNA and protein sequence for example; it is worth
remembering that even these simple data types pose
immensely difﬁcult problems of interpretation, for example
in gene and protein structure prediction). A signiﬁcant
breakthrough in the representation of complex biological
entities in computational biology came with the introduction
of ontologies into bioinformatics [37] and in particular with
the advent of the Gene Ontology (GO) [38]. The Gene
Ontology Consortium contains representatives of a number
of model organism databases, including the Mouse Genome
Database at the Jackson Laboratory. It was a logical step
forward to consider the development of similar ontological
structures for the representation of phenotypes. A
straightforward approach to mouse phenotype information is
taken in the Mammalian Phenotype Ontology [39] (http://
www.informatics.jax.org/userdocs/mp_browser_help.shtml),
which is curated at the Jackson Laboratory. However, as we
have noted already, the exact details of the phenotyping
protocol, genetic background, and environmental conditions
are likely to play a signiﬁcant role in determining the
observed phenotype, and this is not yet taken into account in
the Mammalian Phenotype Ontology. A more recent
development is to use a compound description of phenotype
built up from component ontologies that allows these other
features to be represented [40]. In this approach, the assay
used to ascertain the phenotype information is central, thus
explicitly recognising its importance in descriptions of
phenotype. This combinatorial approach has another
signiﬁcant advantage in that it opens the door to assigning
mice or mouse strains with ontological descriptors, using the
assay as a point of entry to the annotation process: SOPs need
only be annotated once with an ontological description of
what they measure to allow data to be annotated with the
same description. There are still signiﬁcant issues to be
addressed before ontologies of this kind can be wholly
satisfactory, however. For example, frameworks for the
description of environmental conditions as well as a more
complete structure for the description of pathological states
remain to be developed. Further, there are signiﬁcant
theoretical issues, such as how to deal with data that only
indirectly measure phenotypic characters of interest, such as
the results from many behavioural experiments.
A second important issue is the availability of raw
phenotyping data. Just as expression levels of different genes
show patterns of correlation, it seems likely that individual
phenotypic characters will show correlations resulting from
common underlying processes. Mining for such relationships,
especially in the context of genetic differences, would require
the availability of large databases of raw, rather than digested,
data. At present, two databases present raw baseline data for
speciﬁed genetic backgrounds (inbred mouse strains): the
Mouse Phenome Database [32] (http://www.jax.org/phenome)
and EuroPhenome Database (http://www.europhenome.org), a
database that contains the phenotype information derived
from EMPReSS SOPs. Standardised SOPs for phenotyping
are available from the Mouse Phenome Database and the
EMPReSS collection developed by Eumorphia [41] (http://
www.empress.har.mrc.ac.uk/). The Mouse Genome Database
[42] contains a considerable amount of information on
mutant strains annotated using the Mammalian Phenotype
Ontology (http://www.informatics.jax.org/searches/MP_form.
shtml), but this is summary information, extracted largely
from the literature, and does not contain information on
individual mice which would be useful for assessing variability
in a given strain. Some of the larger mouse phenotyping
centres make strain data available via their Web sites, but as
there is no consistent format for data representation or
exchange, these data are also not readily accessible for data
mining. More progress will need to be made towards either an
integrated database of phenotype information or, more
likely, standards for data representation and exchange that
will facilitate downstream analysis.
Conclusion
The challenges in phenotyping awaiting mouse geneticists
as they contemplate the systematic mutagenesis of the mouse
genome are enormous. Overcoming these challenges will ﬁrst
require signiﬁcant technological developments that will
improve both the speed (and cost) as well as the
sophistication of phenotyping measures. Second, providing
phenotype datasets that can be shared and compared will
require continuing efforts to implement standardised
phenotyping protocols and to understand the variables both
in the testing process and the environment that impinge
upon output. Last, we need to continue to develop new
standards for phenotype data representation that
incorporate the phenotype test as well as other variables. The
next step is to begin to apply these requirements in pilot
projects that undertake the systematic phenotype analysis of
a signiﬁcant number of mutants from the new global genome-
wide mutagenesis programmes. “
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